Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

J&J Innovative Medicine

2 abstracts

Abstract
Inferring PDL-1 status from H&E images using digital pathology to identify patients responsive to anti-PD(L)-1 immuno-oncology therapy for bladder cancer trials.
Org: J&J Innovative Medicine, J&J Innovative Medicine, San Diego, CA, J&J Innovative Medicine, Raritan, NJ, J&J Innovative Medicine, Spring House, PA, Johnson & Johnson Innovative Medicine, Cambridge, MA, Research & Development,
Abstract
Treatment patterns with intravesical bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer (NMIBC): A real-world data analysis.
Org: J&J Innovative Medicine, Johnson & Johnson Innovative Medicine, Raritan, Clinical Oncology Center, Research & Development, Immutep, Saint-Aubin, France,